HHS Awards $27.2K BPA for Sterile Pharmaceuticals to American National Services LLC
Contract Overview
Contract Amount: $27,188 ($27.2K)
Contractor: American National Services LLC
Awarding Agency: Department of Health and Human Services
Start Date: 2026-04-07
End Date: 2027-04-06
Contract Duration: 364 days
Daily Burn Rate: $75/day
Competition Type: COMPETED UNDER SAP
Number of Offers Received: 2
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: BLANKET PURCHASE AGREEMENT FOR STERILELY COMPOUNDED PHARMACEUTICALS FOR GALLUP INDIAN MEDICAL CENTER
Place of Performance
Location: PITTSBORO, CHATHAM County, NORTH CAROLINA, 27312
Plain-Language Summary
Department of Health and Human Services obligated $27,187.5 to AMERICAN NATIONAL SERVICES LLC for work described as: BLANKET PURCHASE AGREEMENT FOR STERILELY COMPOUNDED PHARMACEUTICALS FOR GALLUP INDIAN MEDICAL CENTER Key points: 1. Contract awarded to American National Services LLC for sterile pharmaceuticals. 2. The contract is a Blanket Purchase Agreement (BPA) with a firm fixed price. 3. Competition method was 'COMPETED UNDER SAP', indicating a streamlined process. 4. The sector is Pharmaceutical Preparation Manufacturing, crucial for healthcare services.
Value Assessment
Rating: fair
The contract value of $27,187.50 is relatively small. Without specific unit pricing or historical data for similar compounded sterile pharmaceuticals, a precise pricing assessment is difficult. However, the firm fixed price suggests a defined cost structure.
Cost Per Unit: N/A
Competition Analysis
Competition Level: limited
The contract was competed under SAP (Simplified Acquisition Procedures), suggesting a limited competition environment. While this can expedite the process for smaller dollar amounts, it may not always yield the lowest possible price compared to full and open competition.
Taxpayer Impact: The direct taxpayer impact is minimal due to the low contract value. However, ensuring competitive pricing for essential pharmaceuticals is important for overall healthcare cost efficiency.
Public Impact
Ensures availability of essential sterile compounded pharmaceuticals for the Gallup Indian Medical Center. Supports patient care by providing necessary medications. The contract duration of one year with potential for renewal impacts ongoing pharmaceutical supply.
Waste & Efficiency Indicators
Waste Risk Score: 75 / 10
Warning Flags
- Limited competition may impact price optimization.
- Reliance on a single BPA for critical pharmaceuticals.
Positive Signals
- Firm fixed price provides cost certainty.
- Streamlined acquisition process through SAP.
Sector Analysis
This contract falls within the Pharmaceutical Preparation Manufacturing sector, which is vital for healthcare delivery. Spending benchmarks for compounded sterile pharmaceuticals can vary significantly based on drug type, volume, and compounding complexity.
Small Business Impact
Analysis of small business participation is not directly available from the provided data. Further investigation would be needed to determine if small businesses were involved in the competition or subcontracting.
Oversight & Accountability
The use of a Blanket Purchase Agreement (BPA) under SAP suggests a potentially less rigorous oversight compared to larger, more complex contracts. Accountability relies on the terms of the BPA and the performance of American National Services LLC.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Health and Human Services Contracting
- Indian Health Service Programs
Risk Flags
- Potential for higher costs due to limited competition.
- Dependence on a single vendor for critical supplies.
- Lack of detailed performance data in the summary.
- Need for further price benchmarking.
Tags
pharmaceutical-preparation-manufacturing, department-of-health-and-human-services, nc, purchase-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $27,187.5 to AMERICAN NATIONAL SERVICES LLC. BLANKET PURCHASE AGREEMENT FOR STERILELY COMPOUNDED PHARMACEUTICALS FOR GALLUP INDIAN MEDICAL CENTER
Who is the contractor on this award?
The obligated recipient is AMERICAN NATIONAL SERVICES LLC.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (Indian Health Service).
What is the total obligated amount?
The obligated amount is $27,187.5.
What is the period of performance?
Start: 2026-04-07. End: 2027-04-06.
What is the specific breakdown of pharmaceutical preparations covered under this BPA and their respective quantities?
The provided data does not detail the specific pharmaceutical preparations or their quantities included in this Blanket Purchase Agreement. This information is crucial for understanding the scope of services and for conducting a thorough value assessment. Further details would likely be found within the full BPA documentation.
How does the pricing for these compounded sterile pharmaceuticals compare to market rates or other federal contracts for similar items?
A direct comparison of pricing is challenging without specific unit cost data and market benchmarks for these particular compounded sterile pharmaceuticals. While the contract is firm fixed price, the 'COMPETED UNDER SAP' designation suggests potential limitations in price discovery compared to full and open competition. A benchmark analysis against GSA schedules or other IDIQs would be informative.
What is the track record of American National Services LLC in providing sterile compounded pharmaceuticals to federal facilities?
The provided data does not include performance history or past performance evaluations for American National Services LLC. Assessing their track record is essential for understanding the reliability and quality of their pharmaceutical compounding services. This information would typically be available through contract performance reports or federal procurement databases.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: COMPETED UNDER SAP
Solicitation Procedures: SIMPLIFIED ACQUISITION
Offers Received: 2
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 488 CEDAR GROVE RD, PITTSBORO, NC, 27312
Business Categories: Category Business, DoT Certified Disadvantaged Business Enterprise, Limited Liability Corporation, Minority Owned Business, Self-Certified Small Disadvantaged Business, Service Disabled Veteran Owned Business, Small Business, Sole Proprietorship, Special Designations, Indian (Subcontinent) American Owned Business, U.S.-Owned Business, Veteran Owned Business
Financial Breakdown
Contract Ceiling: $54,375
Exercised Options: $27,188
Current Obligation: $27,188
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Timeline
Start Date: 2026-04-07
Current End Date: 2027-04-06
Potential End Date: 2028-04-06 00:00:00
Last Modified: 2026-04-07
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →